Status:
RECRUITING
Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
Lead Sponsor:
Chinese Pulmonary Vascular Disease Research Group
Conditions:
Takayasu Arteritis With Pulmonary Artery Involvement
Percutaneous Transluminal Pulmonary Angioplasty
Eligibility:
All Genders
Brief Summary
1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting t...
Detailed Description
At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu ...
Eligibility Criteria
Inclusion
- patients diagnosed with Takayasu arteries with pulmonary arteries involvement
Exclusion
- Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis
Key Trial Info
Start Date :
January 19 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2042
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05388682
Start Date
January 19 2014
End Date
December 31 2042
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China, 100000